# FDA Inspection 1206233 - Premier Research and Consulting - May 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/premier-research-and-consulting/7cd706d2-c4d8-4300-9324-ff94693a8f06
Source feed: FDA_Inspections

> FDA Inspection 1206233 for Premier Research and Consulting on May 17, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206233
- Company Name: Premier Research and Consulting
- Inspection Date: 2023-05-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/premier-research-and-consulting/3c2e0ed5-2df4-4f2a-810a-5e074b74ad11

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c